Summary

Chronic kidney disease is a common and often silent condition - up to one in ten adults could be affected in Europe, Canada, and Israel, yet only one-third of these will have had a diagnosis.^1,2 Early detection can slow disease progression or even prevent it altogether - which is why testing in at-risk groups is so important.  In this webinar series of 20 minutes each learn how early detection can slow disease progression or even prevent it altogether.

Our international speakers discuss the role of rapid diagnostics in disease prevention with point-of-care testing such as an Albumin Creatinine Ratio (ACR) assay, enabling healthcare providers to detect, and treat, kidney disease in minutes.

Learn more about current guidelines and kidney disease prevention and management.

Learning Objectives

• Importance of regular testing for early detection and monitoring in high-risk patients
• Importance of ACR testing beside the determination of eGFR
• Latest guidance on disease prevention and management
• Case studies

Prof. Trond Jenssen 
Norway

Professor of Nephrology in the Department of Clinical Medicine, University of Oslo, and leader of the Research Group for Transplantation Medicine, Section of Nephrology, Rigshospitalet, Oslo University Hospital

Who Should Watch

Healthcare Professionals, Physicians, Clinicians, Nurses, POC Coordinators